How many ways can this administration kill people?
Scientists tell us that changes to environmental protection laws will lead to at least 80,000 additional deaths each decade.
The announcement that acceptance of refugees fleeing war and persecution will be capped at 30,000 per year–the lowest number ever–has been condemned by Amnesty International, The International Rescue Committee and Human Rights First. What those organizations labeled a “shameful abdication of our humanity” will result in untold numbers of deaths.
The GOP’s solicitude for the “rights” of the NRA continues to facilitate more than thirty thousand gun deaths each year.
Those are all fairly high-profile issues, and at least they’ve generated public debate.
Unfortunately, there has been much less publicity about the government’s ongoing refusal to impose rational regulations on Big Pharma. (Here in Indianapolis, our pathetic excuse for a newspaper simply ignored a recent demonstration protesting Eli Lilly’s pricing of insulin– instead, it ran a front-page “warm and fuzzy” article about the company’s new migraine drug). That failure, too, continues to kill.
If you wonder why single-payer healthcare has become such an overriding political issue, the case of insulin pricing may provide a clue.
Diabetes is one of the most common diseases in the U.S. Its incidence continues to climb, and huge numbers of diabetics are insulin-dependent.
According to information provided by an organization called “Insulin4All”
- the price of insulin has increased 1123% since 1996. This isn’t because of new discoveries–prices have increased on medications that have been around for decades.
- More than 7 million Americans are insulin dependent. More than 25% of those Americans have had to ration their insulin due to cost.
- Over 6,000 GoFundMe pages are asking for money to purchase insulin. (Shane Patrick Boyle, an artist who had moved to Arizona to take care of his mother and was in between health insurance plans, died from diabetic ketoacidosis. He was $50 short in his Go Fund Me for insulin.)
- Some people are paying $1400 a month for their insulin.
The Insulin4All organization is asking two things. First, it wants pharmaceutical companies to disclose their manufacturing costs and profits, along with their marketing expenditures. Second–and incredibly important for all health care, not just diabetes treatment–they want the government to allow Medicare and Medicaid to negotiate drug prices, like other countries’ governments do.
In all fairness, this isn’t the first administration and congress to place the bottom line of drug manufacturers above the needs of sick people needing medicines. It has to stop.
Big Pharma will claim that R & D costs a lot of money, and that those costs justify high prices for their products. It is absolutely true that research and development is costly–but it is also true that a significant percentage of those costs are covered by taxpayers who also deserve a return on their investment.
Since the election, the federal government has cut back on support for basic research (an enormously self-defeating, “penny-wise, pound foolish” policy). Data from the National Science Foundation shows that, since those cutbacks, federal agencies provided “only” 44% of the $86 billion spent on basic research. Before that, however, the federal share of all research routinely topped 70%, and it was 61% as recently as 2004.
In addition, foundations, state and local governments, voluntary health associations and professional societies support drug research and development.
No one is suggesting that Big Pharma forgo a reasonable profit. What is reasonable, however, cannot be determined without increased transparency about actual costs, and the share of those costs coming out of the taxpayers’ pockets.
People who need insulin are dying because they cannot afford it. A lot of people.
Maybe the drug companies could run fewer television ads prompting people to ask their doctors for Purple Pills and the like, and use those savings to bring down the cost of lifesaving medications.
And maybe an administration and a Congress less beholden to corporate interests and big money would consider policies less likely to kill people.Comments